Money in Medicine: Brian Druker on why he gets money from Gilead, not Gleevec

Dr. Brian Druker ’s name is practically synonymous with Gleevec, which is about as close as you can get to a miracle drug. Yet Druker has never directly benefited from Gleevec, which has greatly expanded the life expectancy for those with chronic myeloid leukemia. Because he didn’t invent and patent the drug, h e receives no royalties. He did give a couple of talks about it for drug maker Novartis, but then called it quits on those sorts of gigs. “I decided it was not what I want to be doing,”…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news